Incidental Mutation 'IGL00903:As3mt'
ID |
29490 |
Institutional Source |
Australian Phenomics Network
(link to record)
|
Gene Symbol |
As3mt
|
Ensembl Gene |
ENSMUSG00000003559 |
Gene Name |
arsenite methyltransferase |
Synonyms |
Cyt19, 2310045H08Rik |
Accession Numbers |
|
Essential gene? |
Probably non essential
(E-score: 0.070)
|
Stock # |
IGL00903
|
Quality Score |
|
Status
|
|
Chromosome |
19 |
Chromosomal Location |
46695897-46729538 bp(+) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
A to G
at 46700673 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Isoleucine to Valine
at position 159
(I159V)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000003655
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000003655]
|
AlphaFold |
Q91WU5 |
Predicted Effect |
probably benign
Transcript: ENSMUST00000003655
AA Change: I159V
PolyPhen 2
Score 0.041 (Sensitivity: 0.94; Specificity: 0.83)
|
SMART Domains |
Protein: ENSMUSP00000003655 Gene: ENSMUSG00000003559 AA Change: I159V
Domain | Start | End | E-Value | Type |
Pfam:Methyltransf_23
|
34 |
227 |
2.5e-14 |
PFAM |
Pfam:PCMT
|
64 |
183 |
7.7e-9 |
PFAM |
Pfam:Ubie_methyltran
|
64 |
196 |
8.9e-16 |
PFAM |
Pfam:PrmA
|
65 |
193 |
1.8e-6 |
PFAM |
Pfam:Methyltransf_31
|
70 |
243 |
2e-36 |
PFAM |
Pfam:Methyltransf_18
|
71 |
187 |
9.7e-14 |
PFAM |
Pfam:Methyltransf_25
|
75 |
180 |
2.8e-15 |
PFAM |
Pfam:Methyltransf_12
|
76 |
182 |
2.9e-14 |
PFAM |
Pfam:Methyltransf_11
|
76 |
184 |
2.7e-19 |
PFAM |
low complexity region
|
297 |
310 |
N/A |
INTRINSIC |
|
Coding Region Coverage |
|
Validation Efficiency |
|
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] AS3MT catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (AdoMet) to trivalent arsenical and may play a role in arsenic metabolism (Lin et al., 2002 [PubMed 11790780]).[supplied by OMIM, Mar 2008] PHENOTYPE: Mice homozygous for a null allele have abnormalities in arsenic methylation and in the distribution/retention of orally administered arsenate. [provided by MGI curators]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 27 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
Arsk |
A |
G |
13: 76,246,487 (GRCm39) |
|
probably null |
Het |
Atpsckmt |
T |
C |
15: 31,606,261 (GRCm39) |
V73A |
possibly damaging |
Het |
Ctsll3 |
C |
A |
13: 60,948,075 (GRCm39) |
V201L |
probably benign |
Het |
Dapk1 |
T |
C |
13: 60,909,211 (GRCm39) |
Y1275H |
probably damaging |
Het |
Erap1 |
G |
A |
13: 74,821,826 (GRCm39) |
R727H |
probably benign |
Het |
Fcrl6 |
T |
A |
1: 172,426,674 (GRCm39) |
T91S |
probably benign |
Het |
Gvin1 |
T |
C |
7: 105,757,377 (GRCm39) |
E2364G |
probably benign |
Het |
Hacd3 |
T |
C |
9: 64,911,535 (GRCm39) |
|
probably benign |
Het |
Hcls1 |
T |
A |
16: 36,776,383 (GRCm39) |
|
probably null |
Het |
Igf2r |
C |
T |
17: 12,902,754 (GRCm39) |
R2432H |
possibly damaging |
Het |
Kif27 |
C |
A |
13: 58,492,486 (GRCm39) |
V218F |
possibly damaging |
Het |
Klhl20 |
T |
C |
1: 160,918,076 (GRCm39) |
Y70C |
probably benign |
Het |
Krt86 |
C |
T |
15: 101,371,741 (GRCm39) |
H104Y |
probably benign |
Het |
Lcn12 |
G |
T |
2: 25,383,332 (GRCm39) |
N15K |
possibly damaging |
Het |
Mrgpra1 |
T |
C |
7: 46,985,326 (GRCm39) |
M118V |
probably benign |
Het |
Nacad |
G |
T |
11: 6,550,632 (GRCm39) |
T853K |
probably damaging |
Het |
Nos3 |
A |
T |
5: 24,574,860 (GRCm39) |
Q293L |
probably damaging |
Het |
Prkca |
C |
T |
11: 107,874,800 (GRCm39) |
V381M |
probably damaging |
Het |
Ptcd3 |
A |
G |
6: 71,884,828 (GRCm39) |
F37S |
possibly damaging |
Het |
Ptgs2 |
A |
G |
1: 149,980,175 (GRCm39) |
Y371C |
probably damaging |
Het |
Pygl |
T |
C |
12: 70,254,516 (GRCm39) |
Y143C |
probably damaging |
Het |
Samhd1 |
A |
G |
2: 156,949,343 (GRCm39) |
|
probably benign |
Het |
Scube1 |
T |
A |
15: 83,587,702 (GRCm39) |
H89L |
probably damaging |
Het |
Tmem59l |
G |
A |
8: 70,938,315 (GRCm39) |
|
probably benign |
Het |
Vmn2r108 |
A |
G |
17: 20,682,774 (GRCm39) |
V810A |
probably damaging |
Het |
Vmn2r61 |
T |
G |
7: 41,949,935 (GRCm39) |
F785C |
probably damaging |
Het |
Zfas1 |
G |
T |
2: 166,907,406 (GRCm39) |
|
probably benign |
Het |
|
Other mutations in As3mt |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL00486:As3mt
|
APN |
19 |
46,708,864 (GRCm39) |
missense |
probably benign |
0.06 |
IGL02190:As3mt
|
APN |
19 |
46,708,384 (GRCm39) |
missense |
probably benign |
0.38 |
IGL03088:As3mt
|
APN |
19 |
46,696,233 (GRCm39) |
missense |
probably damaging |
1.00 |
PIT4791001:As3mt
|
UTSW |
19 |
46,708,788 (GRCm39) |
missense |
probably damaging |
1.00 |
R1797:As3mt
|
UTSW |
19 |
46,713,373 (GRCm39) |
missense |
possibly damaging |
0.92 |
R2157:As3mt
|
UTSW |
19 |
46,696,231 (GRCm39) |
missense |
probably benign |
0.36 |
R3113:As3mt
|
UTSW |
19 |
46,703,717 (GRCm39) |
splice site |
probably benign |
|
R3816:As3mt
|
UTSW |
19 |
46,696,216 (GRCm39) |
missense |
probably benign |
0.32 |
R4819:As3mt
|
UTSW |
19 |
46,695,968 (GRCm39) |
unclassified |
probably benign |
|
R5053:As3mt
|
UTSW |
19 |
46,697,493 (GRCm39) |
missense |
probably damaging |
1.00 |
R5333:As3mt
|
UTSW |
19 |
46,696,635 (GRCm39) |
missense |
probably null |
0.97 |
R6003:As3mt
|
UTSW |
19 |
46,696,567 (GRCm39) |
missense |
possibly damaging |
0.85 |
R6269:As3mt
|
UTSW |
19 |
46,708,391 (GRCm39) |
missense |
probably damaging |
1.00 |
R6281:As3mt
|
UTSW |
19 |
46,713,362 (GRCm39) |
missense |
possibly damaging |
0.56 |
R6317:As3mt
|
UTSW |
19 |
46,713,410 (GRCm39) |
missense |
probably benign |
0.01 |
R6803:As3mt
|
UTSW |
19 |
46,698,020 (GRCm39) |
missense |
probably benign |
0.01 |
R7346:As3mt
|
UTSW |
19 |
46,708,891 (GRCm39) |
missense |
probably damaging |
1.00 |
R8061:As3mt
|
UTSW |
19 |
46,728,982 (GRCm39) |
missense |
probably damaging |
1.00 |
R8331:As3mt
|
UTSW |
19 |
46,697,445 (GRCm39) |
missense |
probably damaging |
1.00 |
R9545:As3mt
|
UTSW |
19 |
46,696,233 (GRCm39) |
missense |
probably damaging |
0.97 |
R9697:As3mt
|
UTSW |
19 |
46,708,420 (GRCm39) |
missense |
probably benign |
0.00 |
|
Posted On |
2013-04-17 |